Search Results 61-70 of 16608 for liraglutide

  1. Drugs and Supplements that Start with I - Mayo Clinic

    Insulin degludec and liraglutide (subcutaneous route) · Insulin detemir (subcutaneous route) · Insulin glargine and lixisenatide (subcutaneous route) · Insulin ...

  2. Glyburide (oral route) - Side effects & dosage - Mayo Clinic

    Description. Glyburide is used to treat high blood sugar levels caused by a type of diabetes mellitus (sugar diabetes) called type 2 diabetes.

  3. Leuprolide (intradermal route, intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Leuprolide injection is a synthetic (man-made) hormone that is similar to a natural hormone that is produced in the brain. It is used to treat a number of ...

  4. Glucagon (injection route) - Side effects & dosage - Mayo Clinic

    Glucagon injection is an emergency medicine used to treat severe hypoglycemia (low blood sugar) in diabetes patients treated with insulin who have passed out or ...

  5. A Study of Individualized Obesity Pharmacotherapy Based on Obesity Phenotypes - Mayo Clinic

    ... Liraglutide (Saxenda®). Participants with >1 phenotype based on the following criteria: No match to any phenotype based upon 90th and 75th percentile ...

  6. Ertugliflozin (oral route) - Side effects & dosage - Mayo Clinic

    Ertugliflozin does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use insulin injections. This medicine is ...

  7. Pramlintide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Pramlintide injection is used to treat high blood sugar in patients with type 1 and type 2 diabetes who are also using mealtime insulin and have failed to ...

  8. Drugs and Supplements that Start with I - Mayo Clinic

    Insulin degludec and liraglutide (subcutaneous route) · Insulin detemir (subcutaneous route) · Insulin glargine and lixisenatide (subcutaneous route) · Insulin ...

  9. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    A Mayo Clinic study finds no overall increase in thyroid cancer risk with GLP-1RA therapy, suggesting early diagnoses likely reflect detection bias, ...

  10. Glecaprevir and pibrentasvir (oral route) - Mayo Clinic

    Liraglutide; Lixisenatide; Metformin; Miglitol; Nateglinide; Pioglitazone; Pramlintide; Pravastatin; Repaglinide; Rosiglitazone; Saxagliptin; Semaglutide ...